Full name
VITROLIVE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.22.Z - Specialist medical practice
18 - Printing and reproduction of recorded media
58 - Publishing activities
68.20.Z - Rental and management of own or leased real estate
70.2 - Business and management consultancy activities
71.2 - Technical testing and analysis
72 - Scientific research and development activities
74 - Other professional, scientific and technical activities
85.5 - Non-school forms of education
85.60.Z - Educational support activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | -2 | -0,6 | 69,4 |
Gross profit (loss) | 0,2 | -1,9 | 0,4 | 118,2 |
EBITDA | 0,6 | -1,7 | 0,6 | 134,5 |
Short time liabilities | 0,7 | 0,8 | 1,2 | 50,6 |
Other operating costs | 0 | 0,1 | 0,1 | -59,9 |
Equity capital | 2,8 | 0,8 | 1,2 | 42,8 |
Operating profit (EBIT) | 0,2 | -2 | 0,2 | 107,6 |
Assets | 4,2 | 3,6 | 3,8 | 7,5 |
Net profit (loss) | 0,1 | -1,9 | 0,4 | 118,2 |
Cash | 1,1 | 0,6 | 0,5 | -20,9 |
Net income from sale | 9,1 | 8,3 | 9,4 | 13 |
Liabilities and provisions for liabilities | 1,5 | 2,8 | 2,7 | -3 |
Working assets | 2,8 | 2,1 | 2 | -3,2 |
Other income costs | 0,2 | 0,1 | 0,8 | 503,1 |
Depreciation | 0,3 | 0,4 | 0,4 | 19,4 |
% | % | % | p.p. | |
Profitability of capital | 4,6 | -235 | 30 | 265 |
Equity capital to total assets | 65,4 | 23,1 | 30,6 | 7,5 |
Gross profit margin | 2,5 | -23,2 | 3,7 | 26,9 |
EBITDA Margin | 6,3 | -19,9 | 6,1 | 26 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 29 | 36 | 48 | 12 |
Current financial liquidity indicator | 3.8393733501434326 | 2.5313751697540283 | 1.6269210577011108 | -0,9 |
Net dept to EBITDA | -1.9285284280776978 | 0.37934204936027527 | -0.8698977828025818 | -1,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane